MOUNT PLEASANT, S.C., Feb. 6 /PRNewswire/ -- Revolutions Medical Corporation, Mount Pleasant, SC is pleased to announce an agreement with Strategic Product Development, Inc. which will provide FDA regulatory compliance, manufacturing management capabilities and ongoing product development. “This opportunity to work with Revolutions Medical is exciting, states Richard Theriault, President and CTO of Strategic Product Development. We will put to good use our 20 plus years of experience having developed over 200 products and our knowledge of the highly complex medical industry to bring the patented Reverse Vacuum Safety Syringe quickly to market. Our chief of regulatory affairs, Dave Rothkopf, has over a dozen years of experience bringing products of this type quickly and efficiently through the FDA regulatory process and setting up the systems necessary for FDA quality manufacturing. Our long term relationships both domestic and overseas will also provide Revolutions Medical with excellent proven medical quality manufacturing capabilities.”
“Making sure we have a very experienced team to guide our 3cc Rev Vac Safety Syringe through the FDA application process is paramount to our success. After a long careful review, the Board of Directors has decided to hire Strategic Product Development, Inc. We feel very confident in their experience of getting medical devices quickly approved through the FDA 510K process,” states Ron Wheet, CEO, Revolutions Medical Corporation.
About Revolutions Medical Corporation
Revolutions Medical Corporation operates in the safety-engineered medical devices (SEMDs) arena. Its products include the Rev Vac Safety Syringe, safety blood-drawing device and the Rev Vac Safety IV Catheter. The world market for SEMDs was projected to exceed $1.6 billion last year and is forecasted to maintain a 20% annual growth rate in the near term. The Theta Report estimated the number of needles and syringes sold in the U.S. and International market combined should exceed 20 billion units in 2007.
Revolutions Medical Corporation also provides software solutions and tools that are compatible with standard MRI and standard PACS. Their technology includes sorting of images; grayscale and color, 3D rendering, and automatic segmentation of images. The company is continually looking for new and improved technology through internal product development and acquisition.
Safe Harbor
Forward-looking statements made in this release are made pursuant to the “safe-harbor” provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward- looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty.
Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.
Revolutions Medical Corporation
CONTACT: Scott Key, Investor Relations of Revolutions Medical Corporation,+1-843-408-6265
